medigraphic.com
ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México

2012, Number 1

<< Back Next >>

Arch Med Urg Mex 2012; 4 (1)

Inapropiate use of the gastric antysecretory therapy in the emergency department

Villatoro MA, Carrasco NM, Sánchez GMT

Language: Spanish
References: 30
Page: 6-12
PDF size: 78.62 Kb.


ABSTRACT

Introduction: H2 blockers histamine and therapy of gastric acid suppression have often been prescribed in the hospital for prophylaxis of gastrointestinal bleeding (GI) by acute ulcers in critically ill patients and other diseases, but its accessibility, good tolerance and low side effects have contributed to the abuse in their use. Methods: In the period between: 1/October/2005 to 31/September/2006, reviewed the medical charts of patients hospitalized (observation and/or shock) of ER to the GH CMNR, who met selection criteria. Collecting the data in Office Excel program and analyzed using SPSS 14 (2005), the t Student Test and Kruskal Wallis test was used for statistical analysis with p: ≥ 0.05 as significant. Results: There were 148 women and 106 men (58.26%, 41.73%), with mean age 75 (range 17-105 years). Indicating frequent diagnoses were: gastropathy, infections, and surgical conditions. On admission 13.77% of patients were treated before and during your stay treatment was administered inhibitor of gastric suppression but inappropriately in 86.22% (p ≥ 0.001). Most misused drugs were ranitidine, omeprazole and pantoprazole (p ≥ 0.001) 82.20, 6.20 and 0.39% respectively. Conclusions: We found that treatment was indicated, but no basis in national or international guidelines, revealing that medical personnel requires updating the application of this treatment, as used improperly. The establishment of treatment guidelines in the ED to avoid the overuse of treatments without leaving patients unprotected at the time warrant.


REFERENCES

  1. Noguerado AR, Rodríguez BP, Zelaya CA, Sánchez SF, Antuña BE, García L, Quintana CF, Stellès PM, Alcázar S. Utilización de supresores de la secreción ácida en pacientes hospitalizados. An Med Int 2002; 19 (11): 557-60.

  2. Uso racional da ranitidina na profilaxia da úlcera de stress. Setor de Farmacovigilância do Centro de Vigilância Sanitária do Estado de São Paulo Instituiu o Programa Farmacovigilância Hospitalar em 24 hospitais do Estado São Paulo Brasil 2002. En: http://www.cvs.saude.sp.gov.br/at_05-02.asp. Acceso nov. 10 2006.

  3. Fischer MA, Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. The BWH Division of Pharmacoepidemiology and Pharmacoeconomics. Health Serv Res 2003; 38 (4): 1051-63.

  4. Taxonera SC. Uso inapropiado de los antisecretores en el medio hospitalario. An Med Interna 2002; 19: 555-6.

  5. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000; 95: 3118-22.

  6. Carmona SR, Suazo BJ, González A, Carmona SL, Uscanga DL. Uso y abuso de los bloqueadores de los receptores H2 de la histamina en pacientes hospitalizados. Rev Gastroenterol Méx 1997; 62 (2): 84-88.

  7. Martindale GR. Contemporary strategies for the prevention of stress-related mucosas bleeding. Am J Health Syst Pharm 2005; 62 (Suppl 2): S11-16.

  8. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-321.

  9. Tyba M, Cook D. Current guidelines on stress ulcer prophylaxis. Drugs 1997; 54: 581-596.

  10. Stress bleeding prophylaxis in the surgical critical care patient in Clinical Practice Guideline Manual. UPHS. September 9, 2004. Web site. Accessed October 05, 2005. Available at: http://www.uphs.upenn.edu/surgery/trauma/Links/Stress%20Bleeding%20Prophylaxis.Seervice%20Specific1.pdf.

  11. Doig GS. The use of ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Accessed Oct 02, 2005. Available at: http://www.evidencebased.net.

  12. Cook D, Reeve B, Guyat G, Heyland D, Grifith L, Buckingham L. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 275: 308-314.

  13. Rivkin K, Lyakhovetskiy A. Treatment of nonvariceal upper gastrointestinal bleeding. Am J Health-Syst Pharm 2005; 62 (1): 1159-68.

  14. Rosentock S, Jorgensen T, Bonnevie V, Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2,416 Danish adults. Gut 2003; 52: 186-193.

  15. Cook D, Fuller H, Guyat G, Marshall J, Leaja D, Hall R, Winton T et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330: 377-381.

  16. Smyth M, Zarowitz B. Changing perspectives of stress gastritis prophylaxis. Ann Pharmacother 1994; 28: 1073-1085.

  17. Cook D, Reeve B, Guyat G, Heyland D, Grifith L, Buckingham L, Tyba M. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 275: 308-314.

  18. Hopefl A. Rational use of parenteral proton pump inhibitors. Hospital Pharmacy 2001; 36 (3): 344-350.

  19. Yang YX, Lewis JD. Prevention and treatment of stress ulcers in critically ill patients. Semin Gastrointest Dis 2003; 14: 11-19.

  20. Jong R, McLaren R. Proton pump inhibitors for stress ulcer prophylaxis in critically ill patients. Ann Pharmacother 2002; 36: 1929-37.

  21. Roesch DF, García RV, Rueda TG, Guzmán TT et al. Frecuencia y causas de hemorragia del tubo digestivo alto en la ciudad de Veracruz. Cir Cir 2002; 70: 3-7.

  22. Ghosh S, Watts D, Kinnear M. Management of gastrointestinal haemorrhage. Postgrad Med J 2002; 78: 4-14.

  23. ASHP therapeutic guidelines on stress ulcer prophylaxis. American Society of Health- System Pharmacist. Am J Health Syst Pharm 1999; 56: 347-379.

  24. Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 139: 843-857.

  25. Pingleton KS, Hall BJ, Schmidt AG. Prevention and early detection of complication of critical care. In: Hall BJ, Schmidt AG, Wood LDH. Principles of critical care. 2005: 177-204.

  26. Markovchik VJ. Toma de decisiones en Medicina de Urgencias. En: Markovchik VJ, Pons PT. Secretos de la Medicina de Urgencia. 3ª edición. 2005: 1-4.

  27. Triage, en evaluación y tratamiento iniciales Capítulo. 1. Programa Avanzado de Apoyo Vital en Trauma para médicos, 7ª edición en español. 2005: 15.

  28. Queneau P, Bannwarth B, Carpentier F, Guliana JM, Bouget J, Trombert B et al. Emergency department visits caused by adverse drug events: Results of a french survey. Drug Safety 2007; 30 (1): 81-88.

  29. Orta I A, Carbonell LA, Calvo BDM, Cires PM, Cruz BMA, Delgado MI et al. Manual de buenas prácticas de prescripción. Ed. Academia. La Habana Cuba, 2010: 1-81.

  30. Lavalle-Villalobos A, Payro-Cheng TJ, Martínez-Cervantes KA, Torres-Narváez P, Hernández-Delgado LL, Flores-Nava G. El error médico en la prescripción de medicamentos y el impacto de una intervención educativa. Bol Med Hosp Infant Méx 2007; 64 (2): 83-90.




2020     |     www.medigraphic.com